By [Barbara Stephenson](/content/author/barbara/index.html)  
Posted [March 1, 2019](/content/2019/03/index.html)

In

## WIRED

### Cofactor Genomics

### Recent Posts

- [Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy Test](http://www.businesswire.com/news/home/20250108539488/en/Cofactor-Genomics-Inc.-Announces-CEO-Transition-in-Preparation-for-Accelerated-Commercial-Growth-and-Increased-Patient-Access-for-OncoPrism-its-Medicare-Approved-Immunotherapy-Test)

- [Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer Patients](http://www.businesswire.com/news/home/20241115701491/en/Cofactor-Genomics-expands-clinical-use-of-OncoPrism-as-their-AI-enabled-RNA-test-achieves-national-clinical-validation-after-predicting-immunotherapy-response-in-Lung-Cancer-Patients)

- [Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy](http://www.businesswire.com/news/home/20241107444629/en/Cofactor-Genomics-Publishes-Clinical-Validation-of-OncoPrism-HNSCC-a-Test-Leveraging-Novel-RNA-Modeling-Technology-to-Predict-Response-to-Immunotherapy)

- [Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics’ Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals](http://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals)